The FDA accepted Sanofi’s approval application for Dengvaxia, the dengue vaccine at the center of a safety scandal earlier this year in the Philippines. Now, the agency is set to decide on the vaccine for U.S. approval by May 1, 2019.
The FDA accepted Sanofi’s approval application for Dengvaxia, the dengue vaccine at the center of a safety scandal earlier this year in the Philippines. Now, the agency is set to decide on the vaccine for U.S. approval by May 1, 2019.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
Reageer